The Kaplan–Meier survival analysis revealed that high TEDC2 expression was associated with adverse survival outcomes in patients with ACC, KIRP, KIRC, LUAD, LIHC, and MESO. Here, TEDC2 is linked to adrenal cortex carcinoma.